4
Changes in Ownership
INTERPACE BIOSCIENCES, INC. Filed Acc 0001493152-17-010978
Options or other derivatives
- Chief Commerical Officer acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Richard Gregory Chief Commerical Officer | 2017-09-26 | Grant or award · Stock Option (right to buy) | +200,000 | 200,000 | D: show line 1 in the form |
Loading xslF345X03/form4.xml…